National Center for Advancing Translational Sciences; Notice of Meeting, 79507-79508 [2016-27223]

Download as PDF Federal Register / Vol. 81, No. 219 / Monday, November 14, 2016 / Notices HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Jason E. Bennett, Director, Division of the Executive Secretariat. [FR Doc. 2016–27219 Filed 11–10–16; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Inaugural Meeting of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The U.S. Department of Health and Human Services (HHS) announces the first in a series of federal advisory committee meetings regarding the national health promotion and disease prevention objectives for 2030. The first meeting will be held in the Washington, DC metropolitan area. These meetings will be open to the public. The Committee will review the nation’s health promotion and disease prevention objectives and accomplishments and will recommend goals and objectives to improve the health status and reduce health risks for Americans by the year 2030. The Committee will advise the Secretary on the Healthy People 2030 mission statement, vision statement, framework, and organizational structure. The Committee will provide advice regarding developing criteria for identifying a more focused set of measurable, nationally representative objectives. The Committee’s advice must assist the Secretary in reducing the number of objectives while ensuring that the selection criteria identifies the most critical public health issues that are high-impact priorities supported by current national data sets. DATES: The Committee will meet for two days, December 1, 2016, from 9:00 a.m. to 5:00 p.m. and December 2, 2016, from 8:30 a.m. to 3:00 p.m. Eastern Time. mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:26 Nov 10, 2016 Jkt 241001 The meeting will be held at the 20 F Street Conference Center located at 20 F Street NW., Washington, DC 20001, Conference Rooms A and B. FOR FURTHER INFORMATION CONTACT: Emmeline Ochiai, Designated Federal Officer, Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, 1101 Wootton Parkway, Room LL–100, Rockville, MD 20852, (240) 453–8280 (telephone), (240) 543–8281 (fax). Additional information is available on the Healthy People Web site at http:// www.healthypeople.gov. SUPPLEMENTARY INFORMATION: The names of the 13 members of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 are available at http:// www.healthypeople.gov. Purpose of Meeting: Every 10 years, through the Healthy People initiative, the HHS leverages scientific insights and lessons from the past decade, along with the new knowledge of current data, trends, and innovations, to develop the next iteration of national health promotion and disease prevention objectives. Healthy People provides science-based, 10-year national objectives for promoting health and preventing disease. Since 1979, Healthy People has established and monitored national health objectives to meet a broad range of health needs, encourage collaborations across sectors, guide individuals toward making informed health decisions, and measure the impact of disease prevention and health promotion activities. Healthy People 2030 will reflect assessments of major risks to health and wellness, changing public health priorities, and emerging technologies related to our nation’s health preparedness and prevention. Public Participation at Meeting: Members of the public are invited to observe the Committee meeting. Please note that there will be no opportunity for oral public comments during the inaugural meeting of the Committee. However, written comments are welcomed throughout the development process of the national health promotion and disease prevention objectives for 2030 and may be emailed to HP2030@ hhs.gov. To observe the Committee meeting, individuals must pre-register at the Healthy People Web site at http:// www.healthypeople.gov. Registrations must be completed by close of business ADDRESSES: PO 00000 Frm 00097 Fmt 4703 Sfmt 4703 79507 Eastern Time on November 28, 2016. Space for the meeting is limited and registration will be accepted until maximum room capacity is reached. A waiting list will be maintained should registrations exceed room capacity. Individuals on the waiting list will be contacted as additional space for the meeting becomes available. Registration questions may be directed to: Jim Nakayama at events@ nakamotogroup.com, or (240) 672–4011. Authority: 42 U.S.C. 217a. The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2030 (Committee) is governed by provisions of the Federal Advisory Committee Act (FACA), Public Law 92–463, as amended (5 U.S.C., App.) which sets forth standards for the formation and use of federal advisory committees. Dated: November 4, 2016. Don Wright, Deputy Assistant Secretary for Health, Disease Prevention and Health Promotion. [FR Doc. 2016–27325 Filed 11–10–16; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Cures Acceleration Network Review Board. The meeting will be open to the public, viewing virtually by WebEx. Individuals can register to view and access the meeting by the link below. https://nih.webex.com/nih/onstage/ g.php?MTID=ef62f37f80e52de02d5 c5f72a5f19aace. 1. Click ‘‘Register’’. On the registration form, enter your information and then click ‘‘Submit’’ to complete the required registration. 2. You will receive a personalized email with the live event link. Name of Committee: Cures Acceleration Network Review Board. Date: December 9, 2016. Time: 10:00 a.m. to 3:00 p.m. Agenda: The CAN Review Board will meet virtually to discuss updates regarding CAN programs and next steps. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center E:\FR\FM\14NON1.SGM 14NON1 79508 Federal Register / Vol. 81, No. 219 / Monday, November 14, 2016 / Notices for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301–435–0809, anna.ramseyewing@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: November 7, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–27223 Filed 11–10–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve expeditious commercialization of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Licensing information and copies of the U.S. patent applications listed below may be obtained by writing to the indicated licensing contact at the National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health, 31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892–2479; telephone: 301–402–5579. A signed Confidential Disclosure Agreement may be required to receive copies of the patent applications. SUPPLEMENTARY INFORMATION: Technology descriptions follow. mstockstill on DSK3G9T082PROD with NOTICES SUMMARY: Immortalized Organ of Corti Cell Line OC-k3 Description of Technology Available for nonexclusive licensing as a research material is a conditionally immortalized Organ of Corti cell line called OC-k3. Sensory cells from the auditory organ, the Organ of Corti, are terminally differentiated and cannot be cultured. Moreover, few of them can be isolated per cochlea and survive only VerDate Sep<11>2014 17:26 Nov 10, 2016 Jkt 241001 few hours after isolation making impossible to use on them many biochemical and molecular biology techniques. OC-k3, expresses many markers of sensory cells and it has already been used as an in vitro model for a variety of studies. Potential Commercial Applications • Research • Hearing research • Susceptibility to ototoxic drugs Development Stage • Materials Inventors: Gilda Mabel Canseco de Kalinec and Federico Kalinec (both of NIDCD). Publications 1. Bertolaso L, et al. (2001) ‘‘Apoptosis in the OC-k3 immortalized cell line treated with different agents.’’ Audiology 40:327–335. PMID: 1178104637–5745. 2. Previati M, et al. (2007) ‘‘Cisplatin cytotoxicity in Organ of Corti-derived immortalized cells.’’ J Celt Biochem.101(5):1185–97, PMID: 7243113. Intellectual Property: HHS Reference No. E–012–2017/0—Research Material. Licensing Contact: Michael Shmilovich, Esq, CLP; 301–435–5019; shmilovm@mail.nih.gov. Dated: November 7, 2016. Michael Shmilovich, National Heart, Lung and Blood Institute, Office of Technology Transfer and Development, National Institutes of Health. [FR Doc. 2016–27222 Filed 11–10–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary [Docket No. DHS–2016–0083] Privacy Act of 1974; Computer Matching Program U.S. Citizenship and Immigration Services, Department of Homeland Security. ACTION: Notice of Recertification. AGENCY: This document provides notice of the existence of a computer matching program between the Department of Homeland Security, U.S. Citizenship and Immigration Services and the New Jersey Department of Labor and Workforce Development, titled ‘‘Verification Division DHS–USCIS/NJ– LWD.’’ SUPPLEMENTARY INFORMATION: The Department of Homeland Security, U.S. SUMMARY: PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 Citizenship and Immigration Services provides this notice in accordance with the Privacy Act of 1974 (5 U.S.C. 552a), as amended by the Computer Matching and Privacy Protection Act of 1988 (Public Law 100–503) and the Computer Matching and Privacy Protection Amendments of 1990 (Public Law 101– 508) (Privacy Act); Office of Management and Budget (OMB) Final Guidance Interpreting the Provisions of Public Law 100–503, the Computer Matching and Privacy Protection Act of 1988, 54 FR 25818 (June 19, 1989); and appendix I to OMB’s Revision of Circular No. A–130 (November 28, 2000), ‘‘Transmittal Memorandum No. 4, Management of Federal Information Resources.’’ Participating Agencies: The Department of Homeland Security, U.S. Citizenship and Immigration Services (DHS–USCIS) is the source agency and the New Jersey Department of Labor and Workforce Development (NJ–LWD) is the recipient agency. Purpose of the Match: The purpose of this Agreement is to establish the terms and conditions governing NJLWD’s access to, and use of, the DHS–USCIS Systematic Alien Verification for Entitlements (SAVE) Program, which provides immigration status information from Federal immigration records to authorized users, and to comply with the Computer Matching and Privacy Protection Act of 1988. New Jersey Department of Labor and Workforce Development will use the SAVE Program to verify the immigration status of non U.S. citizens who apply for benefits (Benefit Applicants) under the Unemployment Compensation (UC) benefits that it administers. Under Federal law, immigrant workers must be in particular immigration categories to qualify for UC benefits. NJLWD will use the information obtained through the SAVE Program to determine whether Benefit Applicants possess the requisite immigration status to be eligible for the UC benefits administered by NJLWD. Authority for Conducting the Matching Program: Section 121 of the Immigration Reform and Control Act (IRCA) of 1986, Public Law 99–603, as amended by the Personal Responsibility and Work Opportunity Reconciliation Act of 1996 (PRWORA), Public Law 104–193, 110 Stat. 2168 (1996), requires DHS to establish a system for the verification of immigration status of alien applicants for, or recipients of, certain types of benefits as specified within IRCA, and to make this system available to state agencies that administer such benefits. Section 121(c) of IRCA amends sec. 1137 of the Social Security Act and certain other sections E:\FR\FM\14NON1.SGM 14NON1

Agencies

[Federal Register Volume 81, Number 219 (Monday, November 14, 2016)]
[Notices]
[Pages 79507-79508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27223]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Cures Acceleration Network Review Board.
    The meeting will be open to the public, viewing virtually by WebEx.
    Individuals can register to view and access the meeting by the link 
below. https://nih.webex.com/nih/onstage/g.php?MTID=ef62f37f80e52de02d5c5f72a5f19aace.
    1. Click ``Register''. On the registration form, enter your 
information and then click ``Submit'' to complete the required 
registration.
    2. You will receive a personalized email with the live event link.

    Name of Committee: Cures Acceleration Network Review Board.
    Date: December 9, 2016.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: The CAN Review Board will meet virtually to discuss 
updates regarding CAN programs and next steps.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive 
Secretary, National Center

[[Page 79508]]

for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, 
Bethesda, MD 20892, 301-435-0809, anna.ramseyewing@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: November 7, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27223 Filed 11-10-16; 8:45 am]
 BILLING CODE 4140-01-P